Firstly, we found the increased ANRIL and decreased let-7a in both ovarian cancer tissues and cisplatin-resistant cell lines, especially in those patients with high-clinical stage and high-pathological grade. The gene discussed is CDKN2B-AS1; the disease is ovarian carcinoma.